Preprint
Article

This version is not peer-reviewed.

Zinc Promotes Mitochondrial Health Through PGC-1alpha Enhancing Bacterial Clearance in Macrophages Infected with Mycobacterium avium Complex

A peer-reviewed article of this preprint also exists.

Submitted:

16 July 2025

Posted:

17 July 2025

You are already at the latest version

Abstract
Mitochondria are increasingly recognized as important contributors to immune function in addition to energy production. They do this through modulation of various signaling pathways that regulate cellular metabolism and immune function in response to pathogens. Peroxisome proliferator-activated receptor (PPAR) coactivator 1 alpha (PGC-1) is the primary transcription factor and regulator involved in mitochondrial biogenesis. Long known to be involved in immune function, zinc (Zn) is also required for proper mitochondrial function. It is increasingly recognized that many cellular immunometabolic activities are also Zn dependent. Taken together, we investigated the role of Zn deficiency, both dietary and genetically induced, and Zn supplementation in PGC-1α-mediated macrophage mitochondrial biogenesis and immune function following infection with Mycobacterium avium complex (MAC). Our novel findings show that Zn is an important regulator of PGC-1α and TFAM and mitochondrial biogenesis, leading to enhanced bacterial phagocytosis and bacterial killing in macrophages. Mechanistically, we show that the Zn importer ZIP8 (Zrt/Irt-like protein) orchestrates Zn-mediated effects on PGC-1α and mitochondrial function. Taken together, defective Zn biodistribution may increase susceptibility to infection, whereas Zn supplementation may provide a tractable host-directed therapy to enhance the innate immune response in patients vulnerable to MAC infection.
Keywords: 
;  ;  ;  ;  

1. Introduction

The human immune system is constantly under siege from microbes and pathogens. The respiratory tract, due to constant interaction with airborne pathogens, is especially vulnerable to bacterial exposure, and as such has developed multiple lines of defense to prevent infection. Among the different immune cells that respond to pathogens in the lungs, tissue-resident alveolar macrophages are the front-line responders to inhaled pathogens. Alveolar macrophages play a vital role in host defense and homeostasis, as they phagocytose microbes and cellular debris within the fragile alveolar compartment. This task requires a high level of energy demand and requires proper mitochondrial function for a robust yet balanced response that removes bacteria and restores order. The transcription factor Peroxisome proliferator-activated receptor (PPAR) coactivator 1 alpha (PGC-1α) is the primary energetic regulator that drives mitochondrial biogenesis and turnover. PGC-1α function is influenced through the activity of other transcription factors, including mitochondrial transcription factor A (TFAM) and transcription factor EB (TFEB), in addition to critical cofactors, paramount among them: elemental zinc (Zn).
The atypical transition metal Zn is an indispensable component of many physiological processes, including immunity and metabolism, with over 3000 different proteins and enzymes reliant upon Zn for functional or catalytic activity [1,2,3]. It is well established that Zn is essential for proper immune system function, with dietary-induced deficiency resulting in elevated inflammation and impaired responses to pathogens and excess causing cytotoxicity and cell death [4]. Accordingly, the transport of Zn in and out of cells is tightly regulated to maintain a narrow window of homeostatic concentrations [2,5,6,7,8,9,10]. The primary regulators of intracellular zinc levels are transmembrane transporters belonging to two different families that control intracellular Zn import through Zrt-Irt protein (ZIPs1-14), and export through ZnTs1-10. ZIPs and ZnTs function in a coordinated manner in order to shuttle Zn into and out of cells to always maintain essential cellular function.
Due to high energy requirements that drive host defense, immune cells are highly reliant upon efficient mitochondrial function, which is directly coupled to access to available intracellular Zn. Thus, Zn transport into and out of cells is tightly regulated and a highly controlled process[11]. Deficits in cytosolic Zn through ZIPs or excess accumulation due to defective export through ZnTs can also adversely impact mitochondrial function. Among the Zn-importing family members, our group was the first to reveal that ZIP8 is indispensable in myeloid cell function in response to bacterial infection[12,13,14]. In particular, ZIP8 expression is rapidly induced upon infection and mobilizes Zn from the vasculature into the cytosol, where it then serves a number of functions, resulting in a robust yet balanced proinflammatory response [1]. Loss of ZIP8 expression in bone marrow-derived macrophages and dendritic cells results in a significant reduction in available Zn, an overly exuberant inflammatory response, and reduced bacterial clearance [15].
Nontuberculous mycobacteria (NTM) refer to mycobacteria other than Mycobacterium tuberculosis (M.tb) and M. leprae. NTM are Gram-positive, acid-fast, aerobic bacilli that are ubiquitous in the environment and can be normal inhabitants of natural and drinking water systems, pools, hot tubs, bird droppings, dust, milk, soil, and even laboratory equipment. The incidence and prevalence of NTM-related disease are rising at an alarming rate worldwide. This increase has been attributed to environmental and climate changes, genetic mutations, nosocomial infections, and improved molecular testing. Of significant concern is increasing rates of antibiotic resistance and morbidity associated with prolonged infection, especially in the elderly and non-smoking women. Chronic pulmonary bacterial infections place a heavy immunological burden on lung cells, due to the prolonged and often unrecognized course of infection. Mycobacterium avium complex (MAC) is a species of nontuberculous mycobacterium (NTM) that is present in the environment that humans frequently encounter. Patients with immunodeficiencies, including those with HIV, COPD, cystic fibrosis, or those who use immunosuppressant agents, are at an elevated risk for pathogenic infection and pulmonary complications [16,17,18,19].
Current treatment protocols involve the use of multiple antibiotics for extended intervals, which are becoming less effective due to the emergence of drug-resistant strains. Because of this, alternative treatment options are needed. A relatively new paradigm has emerged that aims to enhance the bactericidal activity of immune cells through host-directed therapies (HDT). Increasing the activity and effectiveness of an individual’s immune cells has the potential to circumvent antibiotic resistance, resulting in improved outcomes. Based on this, we have chosen to identify factors that enhance PGC-1α expression and function in phagocytic cells as a viable strategy to improve bacterial clearance in the lung [20].
Our previous work was the first to reveal that pharmacological activation of PGC-1α has a positive impact on the ability of macrophages to eradicate MAC and other NTMs[21,22,23]. Herein, we reveal that Zn has a positive impact on the expression and activity of PGC-1α and that the Zn transporter ZIP8 serves as a vital conduit for the mobilization of Zn into macrophages in response to NTM infection. First, we show the effects of Zn deficiency and Zn supplementation on antibacterial activity in macrophages. We then reveal that Zn serves as an immunomodulator by regulating mitochondrial function through PGC-1α and related cofactors. Expanding from this, we investigated the effects of Zn supplementation on macrophages to attenuate MAC-mediated deficits in mitochondrial and immune activity. To investigate the mechanism, we utilized a novel ZIP8-KO mouse model to determine the influence of this specific Zn importer on PGC-1α-mediated immune cell function during MAC infection. Our results show the interplay between Zn concentrations and levels of PGC-1α within macrophages, providing a hitherto uninvestigated link between PGC-1α-mediated mitochondria function in immune cells and cellular zinc concentrations.

2. Materials and Methods

2.1. Reagents and Chemicals

The following primers were acquired from Thermo Fisher (Waltham, MA) and used for PCR: ppargc1 (Mm01208835_m1, hs01016719), tfam (Mm00447485_m1, Hs00273372_s1), gapdh (Mm99999915_g1, hs02786624). The following primary and secondary antibodies were used: PGC-1α (Cell Signaling Technology (CST), Danvers, MA 2178), PGC-1α (Santa Cruz Biotechnology (SCBT), Dallas, TX sc-518025), TFAM (CST, 8076), mtTFA (SCBT, sc-166965), β-Actin (CST, 3700), β-Tubulin (CST, 2146) Anti-rabbit IgG HRP (CST, 7074), Anti-mouse IgG HRP (CST, 7076), Goat anti-Rabbit IgG AF 488 (Invitrogen, Waltham, MA, A11008), Donkey anti-Mouse IgG AF 647 (Invitrogen, A31571). MitoTracker Green FM (MTG) (Invitrogen, M7514), Tetramethylrhodamine Methyl Ester (TMRM) (Invitrogen, T668), MitoSOX Red (Invitrogen, M36007) 4′, 6-diamidino-2-phenylindole, dihydrochloride (DAPI) (CST, 4083), Hoechst 33342 (CST, 4082). Unless otherwise specified, reagents and chemicals were obtained through Sigma Aldrich or Thermo Scientific.

2.2. Animal Use and Care

Animals were maintained at the University of Nebraska Medical Center (UNMC) Animal Facility under pathogen-free conditions, with food and water provided ad libitum. Research protocols were approved by the UNMC Institutional Animal Care and Use Committee (IACUC), under protocols 22-007-04-FC and 16-127. Animal care and procedures were performed in accordance with NIH and Office of Laboratory Animal Welfare (OLAW) Guidelines.
Wildtype (WT) mice used were 4-6-week-old female C57BL/6J (The Jackson Laboratory, Bar Harbor, ME). Zip8 knockout mice (Zip8KO) were generated as previously described [24]. Conditional-ready Zip8flox/flox mice from Zip8flox-neo/+ mice (C57BL/6NTac-Slc39a8tm1a(EUCOMM)Wtsi/Cnrm) were obtained from the European Mouse Mutant Archive. Heterozygous Zip8flox-neo/+ mice were bred to ROSA26:FLPe knock-in mice with ubiquitous expression of FLP1 recombinase (129S4/SvJaeSor- Gt(ROSA)26Sortm1(FLP1) Dym/J; Jackson Laboratory) to delete the Neo cassette adjacent to the upstream loxP site. The resulting Zip8flox/+ were mated to produce Zip8flox/flox mice. ZIP8 flox/flox mice were crossed to myeloid cell specific LysMcre (The Jackson Laboratory) to generate the conditional Zip8KO [15,24].

2.3. Cell Culture

Human monocyte cell lines U-937 (CRL-1593.2 ATCC, Manassas, VA) and THP-1 (TIB-202, ATCC) were grown in RPMI media containing 10% fetal bovine serum (FBS) and 1% Penicillin-Streptomycin (PS) and cultured in T75 flasks with media changes every other day. Upon reaching confluence, cells were transferred to 15 mL conical tubes and centrifuged at 1300 x g for 5 minutes. Media was aspirated and the cell pellet resuspended in 1 mL of culture media and filtered through a 70 µm nylon strainer. Cells were counted using a Cell Countess II (Invitrogen) and seeded into plates at the following densities: 6-well 8x105, 12-well 4x105, 96-well 2.5x104. Cells were differentiated into macrophages using PMA [30 ng/mL] for 2 days. Upon differentiation, PMA-containing media was aspirated, wells gently washed with warm PBS and incubated with culture media.
Bone marrow-derived macrophages (BMDM) were harvested from 4-6-week-old adult C57BL/6J mice (The Jackson Laboratory). Briefly, mice were anesthetized with isoflurane and sacrificed via cervical dislocation, and hind legs were aseptically dissected, removed, and femurs were collected in basal RPMI media and placed on ice. The diaphysis of femurs were cut with scissors, and a 27-G needle and syringe with RPMI were used to flush the bone marrow into a 50 mL conical tube. The bone marrow solution was filtered through a 70 µm nylon filter and centrifuged at 1300xG for 6 minutes at 4°C. The supernatant was discarded, and ACK lysing buffer (Gibco) was added to the cell pellet with gentle pipetting to resuspend. An equal volume of RPMI media was added, and the cells were recentrifuged. The supernatant was removed, and cell pellet was resuspended in DMEM culture media containing mouse M-CSF [50 ng/µL]. Cells were plated in tissue culture dishes (Corning) and placed in incubator to allow cells to adhere. Media was changed every other day for 5-7 days until cells became adherent and confluent. Upon reaching confluence, media was aspirated, and dishes gently washed with PBS and incubated for 20 minutes with 0.25% Trypsin. Gentle scraping was used to detach cells, which were added to a 15 mL conical tube with an equal volume of cell culture media. Cells were centrifuged, supernatant removed, and pellet suspended in 1 mL of culture media. Cells were then counted and added to cell culture plates at the following densities: 6-well 1.2x106, 12-well 6x105, 96-well 4.5x104.

2.4. Bacterial Culture

Mycobacterium avium complex (MAC) (MAC 101 70089, ATCC) was cultured in liquid 7H9 media containing 10% OADC (oleic acid, albumin, dextrose, catalase) supplement and placed in an orbital incubator at 300 RPM at 35˚C for ~48 hours until reaching an OD600 of ~0.7. Bacterial suspensions were collected and centrifuged at 13,000 RPM for 12 minutes, the supernatant discarded, the pellet washed in PBS, and recentrifuged. Bacterial pellets were then resuspended in PBS, aliquoted into individual tubes at a concentration of 2x106 cells/µL and stored at -80°C until use [17,18,19].

2.5. Zinc Deficient Media and Zinc Treatment

Zn-deficient media was produced through chelation of FBS. Briefly, 500 mL of heat-inactivated FBS was added to a sterile 1 L Erlenmeyer flask containing 100 g of Chelex-100 (BIO-RAD), and the solution mixed overnight at 4°C. The solution was then filtered, and Zn-free serum aliquoted into 50 mL conical tubes at stored at -80°C. The Zn-free serum was used in place of normal FBS in cell culture media. To induce zinc-deficient conditions, cells were cultured with Zn-free media for 48 hours prior to infection or analysis. Zn treatment utilized ZinPRO® (ZP) supplement. ZP was diluted in sterile ddH2O and used at a final concentration of 50 µM for 48 hours prior to infection or analysis.

2.6. Bacterial Infection

Bacteria were cultured and stored as previously noted. Prior to infection, cell culture media was replaced with media containing no antibiotics. MAC cell pellets were thawed and added to culture media or directly to wells at an MOI of 1 for 4 or 24 hours [17,18,19].

2.7. Total Rna Extraction

Cells in 12-well plates (3513, Corning) were cultured, treated, and infected as previously described in the Materials and Methods section. Total RNA was extracted using the RNeasy Mini Kit (74106, Qiagen) according to manufacturer’s instructions. Briefly, cell culture media was aspirated, wells washed with PBS, and cells lysed and collected through gentle scraping. Lysates were added to RNeasy Mini Spin Columns and briefly centrifuged, with the flow-through discarded. After successive steps of washing and centrifugation with RW1 and RPE buffers, RNA was eluted with nuclease-free water and concentration determined using a NanoDrop One C (Thermo Fisher Scientific, Madison, WI).

2.8. RT-PCR

cDNA was synthesized from isolated total RNA using the SuperScript IV First-Strand Synthesis System (18091050, Invitrogen) according to the manufacturer’s instructions. Briefly, kit components and 1 μg of total RNA were added to an 8-tube strip and reverse transcriptase performed using a T-100 Thermal Cycler (BIO-RAD).
PCR was performed on a QuantStudio 3 Real-Time PCR system (Thermo Fisher). cDNA was mixed with TaqMan Fast Advanced Master Mix (4444557, Applied Biosystems) and primers in a MicroAmp Optical 96-well Reaction Plate (4306737, Applied Biosystems) and sealed with MicroAmp Optical Adhesive Film (4311971, Applied Biosystems). Quantification of mRNA was determined using the ∆∆CT method.

2.9. SDS-PAGE Western BLOT

Cells in 6-well plates (3516, Corning) were cultured, treated, and infected as previously described in the Materials and Methods section. Cell culture plates were placed on ice, media was aspirated, and wells washed with ice-cold PBS. Cell Lysis Buffer (9803, Cell Signaling Technology (CST)) containing Halt Protease and Phosphatase Inhibitor Cocktail (78440, Thermo Scientific) was added to wells and allowed to gently rock on ice for 15 minutes. Cell lysates were collected with gentle scraping, transferred to microcentrifuge tubes, centrifuged at 12,000 RPM for 1 minute at 4°C, and briefly sonicated. Lysates were then centrifuged at 12,000 RPM for 12 minutes at 4°C, and the supernatant collected. Protein concentration was determined through comparison with BSA standards using a Pierce Dilution-Free Rapid Gold BCA Protein Assay Kit (A55860, Thermo Scientific) with absorbance read on a BioTek3 Plate Reader.
Cell lysates were combined with Laemmli 4X buffer (S3401, Sigma Aldrich) and β-Mercaptoethanol and denatured at 75°C for 10 minutes. The reduced lysates were loaded into a 4-15% Mini-PROTEAN TGX SDS PAGE Gel (4561084, BIO-RAD) at a concentration of 30 µg of protein per lane with Precision Plus Protein Kaleidoscope Protein Standards (1610375, BIO-RAD). Gels were resolved in Tris/Glycine/SDS buffer (1610772, BIO-RAD) and run at 125 V for 45 minutes on a PowerPac HC Power Supply (BIO-RAD). Gels were transferred to PVDF membranes in Tris/Glycine buffer (1610771, BIO-RAD) at 10 V overnight at 4°C. Transfer efficiency was determined using Ponceau S Stain (P3504, Sigma Aldrich).
Blots were blocked and primary and secondary antibodies diluted in EveryBlot Blocking Buffer (12010020, BIO-RAD) with extensive washing after each step. Blots were incubated with primary antibodies overnight at 4°C with gentle rocking. Blots were incubated for 1 hour at RT with HRP-conjugated secondary antibody. Protein expression was visualized through the addition of SuperSignal West Femto Maximum Sensitivity Substrate (34094, Thermo Scientific) and imaged on a ChemiDoc MP Imaging System (12003154, BIO-RAD). Blots were stripped using Restore PLUS Western Blot Stripping Buffer (46430, Thermo Scientific) and reprobed with primary and secondary antibodies. Densiometric analysis of bands was performed with ImageJ.

2.10. Immunocytochemistry

Cells were cultured in 96-well plates (Grenier Bio-One), treated and infected as previously detailed. Media was removed from 96-well plates, and wells were washed with PBS three times for 5 minutes each. Cells were fixed with PBS containing 4% paraformaldehyde for 15 minutes, then washed with PBS three times for 5 minutes each. Cells were then permeabilized with PBS containing 0.3% Triton X-100 for 15 minutes and washed with PBS three times for 5 minutes each. PBST containing 5% donkey serum (Gibco) was used for blocking and dilution of antibodies. Cells were blocked for 1 hour at room temperature, and solution removed and replaced with buffer containing primary antibodies overnight at 4°C. Wells were washed with PBS three times for 5 minutes each, and blocking buffer containing fluorescent secondary antibodies was added to wells for 1 hour at room temperature. After removing solution and washing, cells were counterstained with DAPI [1 µg/mL] for 3 minutes, washed again with PBS three times for 5 minutes each. Cells were then imaged on a BZ-X800 confocal microscope (Keyence).

2.11. Mitochondrial Staining

Cells in 96-well plates were cultured, treated, and infected as previously described. Live cell staining utilized MitoTracker Green (MTG) (Invitrogen) and Tetramethylrhodamine methyl ester perchlorate (TMRM) (Life Technologies). Both fluorescent probes were added to HBSS at a 200 nM concentration for mitochondrial staining for 45 minutes at 37°C. The solution was removed, and wells gently washed three times with warm HBSS. Cells were counterstained with Hoechst (Cell Signaling Technology) at a concentration of 1 µg/mL in HBSS for 5 minutes, gently washed, and cell culture media without phenol red was added to wells. Cells were then imaged on a BZ-X800 confocal microscope (Keyence).

2.12. Bacterial Killing

Quantification of macrophage bactericidal activity was determined through colony counting on agar plates. BMDMs were cultured in 24-well plates and treated as previously described, and cells were infected with MAC at an MOI of 1 for 4 hours. Media was aspirated, wells were gently washed twice with HBSS, and 100 µL of PBS containing Triton X-100 (1%) and SDS (0.1%) was added to wells. Cell lysates were collected with gentle scraping and serially diluted in PBS to concentrations of 10-4, 10-5, 10-7. 50 µL of diluted lysate solution was added to 7H9 agar plates and spread across the plate using an L-shaped cell spreader. Plates were placed in an incubator at 37°C and 5% CO2 atmosphere for 5-7 days, and bacterial colonies were counted and converted to CFU/mL(log) [17,18,19].

2.13. Phagocytic Uptake

Phagocytic uptake by macrophages was performed using the Vybrant Phagocytosis Assay (Thermo Fisher) according to manufacturer’s instructions. BMDMs were seeded in 96-well plates and cultured as previously described. Culture media was aspirated, wells were washed with PBS, and 1 mL culture media was added to wells. Wells were gently scraped and collected for centrifugation (1200 g x 6 mins). Cell counts were determined as previously described, and DMEM was added to each tube to a final concentration of 106 cells/mL. One vial of fluorescent particles and HBSS concentrate was thawed, and 0.5 mL HBSS was added to particle vial and briefly sonicated to disperse particles. The suspension was added to a centrifuge tube containing 4.5 mL sterile ddH2O and homogenized the mixture. Cells were added to a 96-well plate at a density of 1x105 cells per well, allowed to adhere for one hour, and 100 µL of the fluorescent particle solution was added to each well and incubated for 2 hours. Media was removed from wells, and 100 µL of the trypan blue solution was added to quench extracellular fluorescence and allowed to incubate for one minute. Trypan solution was aspirated, and fluorescence (480 nm excitation/520 nm emission) was measured on a microplate reader.

2.14. Statistical Analysis

All experiments were performed in triplicate in at least 3 independent experiments, and presented data is the mean +/- standard error. Data were analyzed for statistical significance using Student t-test or ANOVA with Excel (Microsoft, Redmond, WA) or PRISM (GraphPad, San Diego, CA).

3. Results

3.1. Zinc Deficiency During MAC Infection Reduces Expression of Key Transcriptional Regulators of Mitochondrial Biogenesis

Zn is known to modulate the activity of multiple transcription factors and coactivators; thus, we first sought to determine whether Zn deficiency adversely affects mitochondrial biogenesis. PGC-1α and TFAM are key transcriptional regulators of mitochondrial biogenesis and determine mitochondrial health and function that in turn affect macrophage antibacterial function. U937 macrophages were cultured in Zn-deficient conditions for 48 hours prior to and then 24 hours after MAC infection (MOI 1). Cells cultured in Zn sufficient media had reduced ppargc1a and tfam mRNA expression at 24 hours post-infection (HPI). However, Zn deficiency resulted in similar but even lower basal and post-infection mRNA expression levels of ppargc1a (Figure 1A) and tfam (Figure 1B). Similarly, protein expression exhibited the same trend, with Zn deficiency further reducing PGC-1α (Figure 1C,E) and TFAM (Figure 1D,E) following MAC infection. Protein expression was also evaluated immunohistochemically (ICC) and also showed that Zn deficiency reduced PGC-1α (Figure 1F,H) and TFAM (Figure 1G,H), which was further significantly suppressed following MAC infection. Together, these data show that Zn deficiency significantly attenuates the expression of key regulators of mitochondrial biogenesis that likely impact mitochondrial function.

3.2. Zn Deficiency Induces Mitochondrial Damage, Increases Mitochondrial ROS Production, and Attenuates Bacterial Clearance

To determine the effect of Zn deficiency on mitochondrial health in MAC-infected macrophages, we evaluated ΔΨm and mitochondrial ROS production. MAC infection significantly reduced the integrity of the mitochondrial membrane potential, which was exacerbated by Zn deficiency (Figure 2A,B). Damage to the mitochondria can result in excess production of reactive oxygen species (ROS), which can leak from the electron transport chain (ETC) into the surrounding intracellular environment. ROS superoxide production was evaluated through fluorescent expression of MitoSOX. Macrophages infected with MAC exhibited a significant elevation in MitoSOX fluorescence, indicative of excessive production of superoxide, which was significantly increased under Zn-deficient conditions (Figure 2C). Next, we investigated the influence of Zn deficiency on the antibacterial activity of macrophages through evaluating phagocytic uptake and killing of ingested microbes. U937 macrophages were cultured under Zn-deficient conditions for 48 hours and incubated with opsonized fluorescent E. coli Bioparticles (MOI 2) for 2 hours. After washing to remove extracellular bacteria, fluorescence was measured on a microplate reader (480 nm ex/520 nm em) to compare the relative amounts of phagocytic uptake. Zn deficiency resulted in significantly lower phagocytosis compared to Zn-sufficient controls (Figure 2D). The ability of macrophages to kill internalized MAC was evaluated by quantification of colony-forming units (CFUs). U937 macrophages were cultured under normal or Zn-deficient conditions for 48 hours, infected with MAC (MOI 1) for 4 hours, then incubated with gentamycin-containing media to kill extracellular bacteria. Cells were lysed 24 hours post-infection, and the lysate was added to 7H9 agar plates for quantitation of CFUs. Zn deficiency resulted in significantly higher CFUs than control cells, indicative of an elevated bacterial burden and reduced ability to kill MAC (Figure 2E). These data indicate that Zn deficiency causes reduced phagocytosis; however, bacteria that are ingested accumulate over time due to compromised intracellular MAC clearance.

3.3. ZP Treatment Restores PGC-1α and TFAM Expression Following MAC Infection.

While our previous results demonstrate the negative impact of Zn deficiency during MAC infection on PGC-1α and TFAM, we sought to determine whether Zn supplementation can restore their expression. ZinPRO® (ZP), a 1:1 Zn-lysine; Zn-glutamine complex, is an organic commercially available Zn supplement. U937 macrophages were cultured with ZP [50 μM] for 48 hours and infected with MAC (MOI 1) for 24 hours prior to collection for mRNA and protein analysis. Treatment with ZP increased ppargc1a (Figure 3A) and tfam mRNA expression (Figure 3B), resulting in expression levels significantly higher compared to MAC infection alone. Protein expression exhibited a similar trend, with MAC infection significantly decreasing expression of PGC-1α (Figure 3C,E) and TFAM (Figure 3D,E). ZP treatment significantly increased PGC-1α (Figure 3C,E) and TFAM (Figure 3D,E). Protein expression was also evaluated and visualized through immunohistochemistry (ICC) and confocal microscopy, with results in agreement with the Western blots. MAC infection significantly reduced fluorescence expression of both PGC-1α (Figure 3F,H) and TFAM (Figure 3G,H). Again, pretreatment with ZP abrogated the MAC-mediated decreases in PGC-1α (Figure 3F,H) and TFAM (Figure 3G,H). Treatment with ZP also resulted in significantly elevated PGC-1α expression compared to untreated controls (Figure 3F,H). Together, these results indicate that zinc supplementation restores the expression of transcriptional regulators of mitochondrial biogenesis, thus enhancing mitochondrial function in response to MAC infection.

3.4. ZP Treatment Reduces Mitochondrial Damage, Decreases Mitochondrial ROS Production, and Improves Bacterial Clearance

Since ZP treatment improved PGC-1α and TFAM mRNA and protein expression in response to MAC infection, we next determined the impact of ZP on mitochondrial health and macrophage immune function. We utilized MitoSOX to evaluate superoxide production during MAC infection as described above. U937 macrophages were pretreated with ZP [50 μM] for 48 hours, followed by MAC (MOI 1) infection for 4 hours, and MitoSOX was measured by fluorescence. In agreement with our previous results, MAC infection significantly increased superoxide production compared to controls (Figure 4C). ZP treatment did not exhibit a significant difference in MitoSOX fluorescence compared to control but significantly attenuated superoxide production in response to MAC infection (Figure 4C). We next evaluated the influence of ZP on macrophage phagocytic uptake. Compared to control, ZP-treated macrophages exhibited a significant increase in bacterial uptake compared to untreated controls (Figure 4D). To determine the effect of ZP on bactericidal activity of macrophages, cells were pretreated with ZP [50 μM] prior to infection (MOI 1) for 4 hours, then lysed and plated on 7H9 agar to determine CFU counts. ZP-treated macrophages exhibited elevated intracellular killing of MAC, resulting in a significantly lower number of colonies compared to controls (Figure 4E). These results demonstrate that ZP treatment helps to maintain mitochondrial membrane potential and reduce mitochondrial damage resulting in enhanced macrophage bacterial clearance.

3.5. ZIP8 Loss Reduces Expression of Key Transcriptional Regulators of Mitochondrial Biogenesis in Response to MAC Infection

We have previously reported that ZIP8 is the only Zn transporter that is highly induced following bacterial infection and regulates myeloid cell function in a Zn-dependent manner [15]. Therefore, we sought to investigate the role of ZIP8 following MAC infection as it relates to PGC-1α and TFAM and mitochondrial biogenesis. Cells were harvested from the bone marrow of WT (control) and ZIP8KO mice and differentiated as previously described [15]. BMDMs were then cultured under Zn-deficient conditions for 48 hours prior to MAC infection (MOI 1) for 24 hours. WT and KO BMDMs had similar mRNA expression of ppargc1a (Figure 5A) and tfam (Figure 5B) under control conditions; however, MAC infection significantly decreased mRNA and protein expression of both factors in ZIP8KO cultures compared to WT counterparts (Figure 5A,B and Figure 5C,E, respectively). The differences in TFAM expression between WT and KO cells were less pronounced, with control cells not exhibiting a significant difference (Figure 5D,E). This trend was also observed using ICC, with significantly reduced fluorescence expression of PGC-1α and TFAM in KO cells compared to WT counterparts (Figure 5F,H). These results provide evidence that intracellular Zn deficiency as a consequence of ZIP8 loss also reduces the expression of key mitochondrial transcription regulators, thus exacerbating mitochondrial dysfunction.

3.6. ZIP8 Loss Enhances MAC-Induced Mitochondrial Damage, Increased Mitochondrial ROS Production, and Decreased Bacterial Clearance

Knowing that ZIP8KO loss resulted in significantly reduced PGC-1α expression, we determined whether this corresponded with impairment of mitochondrial health and antibacterial activity in BMDMs. We first determined mitochondrial health via the impact on ΔΨm and energy production. WT and KO BMDMs were infected with MAC (MOI 1) for 4 hours. Cells were then incubated with MTG and TMRM and subjected to confocal microscopy. No significant differences were observed between WT and KO cells under control conditions (Figure 6A). However, MAC infection induced a significant decrease in TMRM fluorescence in both WT and KO BMDMs, with KO cells exhibiting larger decrease compared to WT. This also corresponded with a substantial decrease in fluorescence expression in the KO cells compared to their WT counterparts (Figure 6A). We did not observe differences in mitochondrial ROS formation under control conditions (Figure 6B). As anticipated, MAC infection increased ROS production in both WT and KO BMDMs, with KO cells exhibiting significantly higher ROS production compared to WT cultures, with KO cells exhibiting a near 7-fold increase in superoxide production compared to control WT cells (Figure 6B). These data provide evidence that ZIP8 loss substantially increases mitochondrial ROS production and mitochondrial damage in response to MAC infection. To determine whether it may influence the antibacterial activity of macrophages, we compared phagocytic uptake and intracellular killing of MAC in WT and KO BMDMs. Similar to BMDMs under Zn-deficient conditions, ZIP8KO cells exhibited a significant decrease in phagocytic uptake compared to the WT (Figure 6D). Also, similar to Zn-deficient conditions, KO cells exhibited a significant increase in CFUs compared to WT cultures (Figure 6E), indicative of a higher bacterial burden despite reduced phagocytic uptake.

3.7. ZP Treatment Restores PGC-1α and TFAM Expression Following MAC Infection of ZIP8KO BMDMs

Human studies have revealed that a frequently occurring ZIP8 variant allele can lead to defective intracellular transport of Zn and is strongly associated with bacterial infections (Ye 2014). In our previous work, we revealed that Zn pyrithione, which obviates the need for ZIP-mediated transport, can restore host defense in ZIP8KO macrophages against S. pneumoniae infection (Hall et al., 2021). Thus, we determined whether ZP supplementation, which also does not require ZIP-mediated transport, can restore antibacterial function in ZIP8 KO BMDMs. WT and KO BMDM cultures were treated with ZP [50 μM] for 48 hours, and infected with MAC (MOI 1) for 4 hours prior to analysis for mRNA and protein expression. mRNA expression of ppargc1a was reduced in KO cells compared to WT controls, and ZP treatment resulted in a modest increase in both WT and KO BMDMs (Figure 7A). As previously observed, MAC infection significantly reduced ppargc1a expression in both WT and KO cells, with the latter exhibiting a more drastic decrease. However, ZP treatment was able to attenuate this decrease. KO BMDMs treated with ZP and infected with MAC exhibited a significant increase in ppargc1a (Figure 7A) and tfam (Figure 7B) mRNA expression compared to infection alone. Protein expression was evaluated by immunohistochemistry (Figure 7C–E). This corresponded with a significant increase in PGC-1α and TFAM, which was more significantly elevated in KO cells with ZP treatment compared to WT control cultures (Figure 7C,D). These results reveal that ZP supplementation prior to and during MAC infection restores mitochondrial biogenesis despite ZIP8 loss, which may have tractable clinical implications in the treatment of NTM disease.

3.8. ZP Attenuates Mitochondrial Damage and Deficits in Macrophage Antibacterial Activity During MAC Infection in ZIP8 Knockout Macrophages

Next, we determined whether ZP could reduce mitochondrial damage and improve antibacterial activity despite ZIP8 loss. As before, we evaluated mitochondrial membrane integrity and ROS production under identical conditions. We observed no significant difference between controls and ZP-treated cultures at baseline. MAC infection resulted in a significant increase in TMRM fluorescence in both WT and KO cultures (Figure 8A). ZP treatment improved mitochondrial membrane potential following MAC infection in both WT and KO cells, as seen by significant increases in fluorescence compared to infection alone. KO BMDMs appeared to be more sensitive to mitochondrial damage during MAC infection, as they exhibited significantly less fluorescence expression compared to their WT counterparts (Figure 8A). Differences in ROS production were observed in WT and KO BMDMs following MAC infection, with KO cells exhibiting a more significant increase in superoxide production compared to WT cultures (Figure 8B). ZP treatment resulted in decreased ROS detection in WT and KO cultures in response to MAC infection. Phagocytic uptake was measured as before, with WT and KO BMDMs treated with ZP [50 μM] for 48 hours and incubated with fluorescent bacteria for 2 hours prior to analysis. As previously observed, WT cells exhibited an increase in particle uptake compared to KO cells (Figure 8C). ZP treatment had a positive effect on phagocytic uptake in both WT and KO cells, with both exhibiting significant increases compared to control. As expected, KO BMDMs exhibited a reduced capacity for killing bacteria, resulting in a significantly higher bacterial burden than the WT (Figure 8D), but this was reversed following ZP treatment, resulting in a significant increase in intracellular killing of MAC in both WT and KO cells, with each cell type having significantly less bacteria growth than the untreated cells. These results indicate that ZP has mitochondrial protective properties that can overcome loss of ZIP8 and, by doing so, enhance the antibacterial activity of macrophages against MAC infection.

4. Discussion

Alveolar macrophages are the primary cell involved in the initial innate immune response against intracellular pathogens [25,26,27,28]. Due to their “first responder” status, alveolar macrophages require a high metabolic rate to dispatch encountered bacteria. High energy demand is predicated upon highly efficient mitochondrial function to power the cellular machinery involved in bactericidal activities [26,27,28,29,30]. Here, we investigated the role of Zn in regulating mitochondrial biogenesis, which is critical to rejuvenate mitochondria for effective ATP production and a robust host immune response. Our data show that Zn enhances the expression of PGC-1α and TFAM, critical transcriptional regulators of mitochondrial biogenesis. Mechanistically, we show that the Zn importer ZIP8 (Zrt/Irt-like protein) regulates Zn-mediated effects on PGC-1a and mitochondrial function.
PGC-1α is a key regulator of mitochondria biogenesis, an important quality control mechanism to maintain metabolic function of macrophages. Increased expression provides cellular signals required for the maintenance and generation of new mitochondria [31,32,33,34,35]. It is also well established that Zn is required for proper immune function. For the first time, we provide evidence demonstrating a novel Zn-dependent requirement for PGC-1α expression in macrophages in response to MAC infection [2,3,36]. This observation is consistent with other studies demonstrating the essential role of Zn in maintaining lung immune function. In particular, insufficient Zn levels due to restricted dietary intake before respiratory tract infection result in bacterial evasion of the immune system and worse outcomes [2,6,15,24,37,38,39,40].
The acquisition and progression of respiratory tract infections are known to be influenced by chronic Zn deficiency, due to the importance of Zn in a myriad of immune cell functions [2,3]. Populations that are most vulnerable to community-acquired pneumonia also exhibit a high incidence of Zn deficiency [41,42,43] , which is estimated to impact approximately 2 billion people worldwide, including approximately 20-30% of the U.S. population [44]. Consistent with this, others have reported that dietary Zn deficiency increases susceptibility to gastrointestinal tract infections [45] and pneumonia [46,47] , whereas the incidence of pneumonia and other infections is decreased with Zn supplementation [48,49,50].
Mice fed Zn-deficient diets were significantly more susceptible to Streptococcus pneumoniae infection than their Zn-sufficient counterparts, exhibiting a higher bacterial burden, elevated inflammatory cytokine production, and a drastic decrease in survival [40]. Acinetobacter baumannii is a Gram-negative bacterium that is frequently linked to respiratory infections during intubation, resulting in ventilator-associated pneumonia [51]. Zinc deficiency also influenced the progression of A. baumannii in vivo in a mouse model, with mice fed a Zn-deficient diet exhibiting a significant bacterial burden in lung tissue and BAL fluid compared to Zn-replete mice [51]. In our previous study investigating infection with S. pneumoniae we utilized a novel Zip8 KO mouse to determine its effect on immune cell function against infection. Despite being maintained on a sufficient Zn diet, ZIP8 loss in myeloid cells resulted in decreased acquisition of intracellular Zn that also resulted in increased bacterial burden in the lung, bacterial dissemination into other tissues, increased inflammation and collateral tissue damage, and increased mortality, similar to findings associated with inadequate dietary intake [15]. This has clinical relevance, as human genome-wide association (GWAS) studies revealed that a frequently occurring defective ZIP8 variant allele (rs13107325; Ala391Thr risk allele) is highly associated with inflammation-based diseases [52,53] and bacterial infections [54]. In fact, a comprehensive review of human GWAS studies revealed that the SLC39A8 variant allele is in the top ten of all variant alleles associated with human disease [53]. Collectively, these studies highlight the essential requirement for Zn and its bioredistribution in response to bacterial invasion in order to mount an effective yet balanced host innate immune response [55]. Our studies are the first to show the importance of zinc deficiency and supplementation on macrophage function in MAC infection.
MAC is ubiquitously present and found in water sources and soil and can be pathogenic in patients with compromised immune systems and chronic lung diseases, including cystic fibrosis, chronic obstructive pulmonary disease, and bronchiectasis [56,57,58,59,60,61]. MAC infections typically arise from exposure to environmental niches in the water and soil, whereas person-to-person transmission is uncommon [58]. The increasing number of cases is due in part to the emergence of drug-resistant strains, complicating treatment of an already evasive and difficult-to-treat pathogen. Currently, the standard of care is long-term treatment (12-18 months) with multiple antibiotics, which are often difficult to tolerate. Furthermore, a significant number of patients experience recurrence of infection despite prolonged treatment [61]. Thus, there is a high demand for alternative treatment modalities, particularly host-directed therapies that can enhance MAC clearance.
Zn, in addition to other transition metal ions, is also utilized by bacteria for growth and metabolic processes, and immune cells have adapted to this shared need for cations between pathogens through a process known as nutritional immunity [36,62,63]. During infection, metal ions can either be sequestered to prevent their use and uptake by pathogens or concentrated in cellular compartments in excess to induce toxicity in the invading microbes [7,63]. Within the body, Zn possesses secondary messenger functions involved in immune cell recruitment and differentiation. Phagocytic uptake of microbes by macrophages is influenced by the presence of Zn, with ZIP8 expression being rapidly upregulated in response to pathogens to increase intracellular Zn concentrations [1,55]. Zn also influences the activity of other immune cells, with neutrophils exhibiting reduced recruitment, migration, and phagocytosis under conditions of Zn deficiency. Similarly, both mast cells and NK cells utilize Zn to regulate their immune functions, with Zn starvation resulting in deficient immune activity [11].
Our results show that insufficient intracellular Zn adversely impacts mitochondrial function via reduction in PGC-1α expression in response to MAC. We also reveal that this deficit can be attenuated through Zn supplementation. Instead of supplementing with conventional inorganic Zn salts such as ZnCl2 or ZnSO4, we used a ZinPro® (ZP) formulation that is Zn conjugated to lysine and glutamine, provided in equal amounts. Previously, it has been shown to have superior bioavailability to inorganic Zn via amino acid transporter-coupled uptake. Using FluoZin-3 AM, a cell-permeant intracellular fluorescent Zn indicator, we observed a significantly higher intracellular Zn concentration with ZP compared to ZnCl2 at equivalent molar concentrations.
We provide evidence that the availability of zinc influences PGC-1α expression and sought to determine the mechanism of cellular zinc import. The ZIP family contains 14 members, with variable presence and expression dependent upon tissue location and type. The predominant ZIP in lung tissues is ZIP8, leading us to select it as a potential target influencing PGC-1α expression and related mitochondrial function.
Our previous research investigated the influence of PGC-1α in NTM infections in macrophages, where expression was modulated through treatment with specific activators and inhibitors to determine the effect on macrophage antibacterial activity in nontuberculous mycobacterium (NTM) infections [21]. PGC-1α is a transcription factor and master regulator of mitochondrial biogenesis, influencing the creation and turnover of mitochondria. Functioning in concert with PGC-1α, mitochondrial transcription factor A (TFAM) is responsible for maintenance and synthesis of mitochondrial DNA (mtDNA), influencing the activity and health of mitochondria. Within the scope of immunity, mitochondrial function drives immune cell activity and function through energy production and metabolism, in addition to important cellular signaling activities. The process of pathogen clearance that includes initial recognition, phagocytic uptake, and eventual lysosomal degradation requires a high energetic demand and metabolic input. Thus, mitochondria are indispensable for protection against bacteria and other pathogens. Revealing that PGC-1α is reliant upon Zn for proper expression and activity provides a new paradigm that involves dietary intake, or lack thereof, and proper biodistribution, via improved formulation and/or ZIP-mediated transport and immunometabolism, resulting in effective clearance of MAC by macrophages.
Our study shows that infection with MAC significantly induces mitochondrial ROS production, which perpetuates mitochondrial damage, compromising macrophage function. In accordance with this, MAC-infected cells exhibited decreased MMP and physical disruption and loss of integrity of the inner mitochondrial membrane (IMM), which is required for ATP production. Upon damage to the IMM, the release of ROS and mtDNA triggers mitochondrial-mediated inflammatory signaling, inducing morphological changes that, if unaddressed, lead to cell death. In this study, we reveal that the deleterious effect of MAC upon macrophages was heightened by dietary-induced and genetically-induced Zn deficiency in vitro. Importantly, Zn supplementation with a more bioavailable Zn formulation (ZP) attenuated mitochondrial damage and restored macrophage antibacterial function.
These studies are the first to highlight the vital role of Zn in maintaining mitochondrial health in response to MAC infection in macrophages and demonstrate its beneficial impact on PGC-1α. To determine whether Zn impacts PGC-1α-mediated mitochondrial function, we modified culture conditions to emulate dietary-induced Zn deficiency and genetically induced Zn deficiency (ZIP8 loss), and with both conditions also supplemented Zn, then evaluated the impact on mitochondrial function and antibacterial activity. Our results consistently revealed an indispensable role of Zn in macrophage function and their ability to eradicate MAC. As this invasive species continues to evolve new mechanisms to evade host defense, we need to aggressively pursue novel yet tractable treatments to succeed in this pathogenic arms race. Host-directed therapies designed to enhance natural immune cell function are widely becoming an integral focus in the future of antibacterial treatments. Based on our findings, screening approaches that identify Zn insufficiency due to dietary genetic and genetic defects have the potential to foster tolerable preventive and supplemental treatment strategies that more effectively resolve pulmonary MAC infection.

Acknowledgments

Funding sources-RTS- I01BX001786 Merit Review Award, Department of Veterans Health, NIH RO1- HL144478.

References

  1. Chen B, Yu P, Chan WN, Xie F, Zhang Y, Liang L, Leung KT, Lo KW, Yu J, Tse GMK et al.: Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. Signal Transduct Target Ther 2024, 9(1):6.
  2. Luan R, Ding D, Xue Q, Li H, Wang Y, Yang J: Protective role of zinc in the pathogenesis of respiratory diseases. Eur J Clin Nutr 2023, 77(4):427-435.
  3. Wessels I, Fischer HJ, Rink L: Update on the multi-layered levels of zinc-mediated immune regulation. Semin Cell Dev Biol 2021, 115:62-69.
  4. Knoell D, Rink L: Metal ions in immune function and host defense. Semin Cell Dev Biol 2021, 115:1-2.
  5. Yang Y, Wang P, Guo J, Ma T, Hu Y, Huang L, Xing B, He Y, Xi J: Zinc Overload Induces Damage to H9c2 Cardiomyocyte Through Mitochondrial Dysfunction and ROS-Mediated Mitophagy. Cardiovasc Toxicol 2023, 23(11-12):388-405.
  6. Liu X, Ali MK, Dua K, Xu R: The Role of Zinc in the Pathogenesis of Lung Disease. Nutrients 2022, 14(10).
  7. Knies KA, Li YV: Zinc cytotoxicity induces mitochondrial morphology changes in hela cell line. Int J Physiol Pathophysiol Pharmacol 2021, 13(2):43-51.
  8. Dierichs L, Kloubert V, Rink L: Cellular zinc homeostasis modulates polarization of THP-1-derived macrophages. Eur J Nutr 2018, 57(6):2161-2169.
  9. Gao H, Dai W, Zhao L, Min J, Wang F: The Role of Zinc and Zinc Homeostasis in Macrophage Function. J Immunol Res 2018, 2018:6872621.
  10. Bauer CD, Mosley DD, Samuelson DR, Poole JA, Smith DR, Knoell DL, Wyatt TA: Zinc Protects against Swine Barn Dust-Induced Cilia Slowing. Biomolecules 2024, 14(7).
  11. Jin D, Wei X, He Y, Zhong L, Lu H, Lan J, Wei Y, Liu Z, Liu H: The nutritional roles of zinc for immune system and COVID-19 patients. Front Nutr 2024, 11:138559.
  12. Samuelson DR, Smith DR, Cunningham KC, Wyatt TA, Hall SC, Murry DJ, Chhonker YS, Knoell DL: ZIP8-Mediated Intestinal Dysbiosis Impairs Pulmonary Host Defense against Bacterial Pneumonia. Int J Mol Sci 2022, 23(3).
  13. Samuelson DR, Smith DR, Cunningham KC, Haq S, Villageliu DN, Ellis CM, Chowdhury NB, Ramer-Tait AE, Price JD, Knoell DL: The Inherited Intestinal Microbiota from Myeloid-Specific ZIP8KO Mice Impairs Pulmonary Host Defense against Pneumococcal Pneumonia. Pathogens 2023, 12(5).
  14. Samuelson DR, Haq S, Knoell DL: Divalent Metal Uptake and the Role of ZIP8 in Host Defense Against Pathogens. Front Cell Dev Biol 2022, 10:924820.
  15. Hall SC, Smith DR, Dyavar SR, Wyatt TA, Samuelson DR, Bailey KL, Knoell DL: Critical Role of Zinc Transporter (ZIP8) in Myeloid Innate Immune Cell Function and the Host Response against Bacterial Pneumonia. J Immunol 2021, 207(5):1357-1370.
  16. Mirsaeidi M, Farnia P, Sadikot R, Hsueh PR, Aliberti S: Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects. Biomed Res Int 2015, 2015:523697.
  17. Choi SR, Britigan BE, Switzer B, Hoke T, Moran D, Narayanasamy P: In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Molecular pharmaceutics 2018, 15(3):1215-1225.
  18. Choi SR, Switzer B, Britigan BE, Narayanasamy P: Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit Mycobacterial Species by Targeting Different Aspects of Iron/Heme Metabolism. ACS Infect Dis 2020, 6(10):2582-2591.
  19. Choi SR, Talmon GA, Britigan BE, Narayanasamy P: Nanoparticulate beta-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium. ACS Infect Dis 2021, 7(8):2299-2309.
  20. Maurice NM, Bedi B, Yuan Z, Goldberg JB, Koval M, Hart CM, Sadikot RT: Pseudomonas aeruginosa Induced Host Epithelial Cell Mitochondrial Dysfunction. Scientific reports 2019, 9(1):11929.
  21. Frandsen JR, Yuan Z, Bedi B, Prasla Z, Choi SR, Narayanasamy P, Sadikot RT: PGC-1alpha activation to enhance macrophage immune function in mycobacterial infections. PLoS One 2025, 20(2):e0310908.
  22. Maurice NM, Sadikot RT: Mitochondrial Dysfunction in Bacterial Infections. Pathogens 2023, 12(8.
  23. Prasla Z, Sutliff RL, Sadikot RT: Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections. Am J Respir Cell Mol Biol 2020, 63(2):144-151.
  24. Knoell DL, Smith D, Bao S, Sapkota M, Wyatt TA, Zweier JL, Flury J, Borchers MT, Knutson M: Imbalance in zinc homeostasis enhances lung Tissue Loss following cigarette smoke exposure. J Trace Elem Med Biol 2020, 60:126483.
  25. Gao X, Zhu B, Wu Y, Li C, Zhou X, Tang J, Sun J: TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis. J Immunol 2022, 208(6):1456-1466.
  26. Park HE, Lee W, Choi S, Jung M, Shin MK, Shin SJ: Modulating macrophage function to reinforce host innate resistance against. Front Immunol 2022, 13:931876.
  27. Dong T, Chen X, Xu H, Song Y, Wang H, Gao Y, Wang J, Du R, Lou H: Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases. Pharmacol Ther 2022, 239:108208.
  28. Wang Y, Li N, Zhang X, Horng T: Mitochondrial metabolism regulates macrophage biology. J Biol Chem 2021, 297(1):100904.
  29. Kumar M, Sharma S, Kumar J, Barik S, Mazumder S: Mitochondrial electron transport chain in macrophage reprogramming: Potential role in antibacterial immune response. Curr Res Immunol 2024, 5:100077.
  30. Nassef MZ, Hanke JE, Hiller K: Mitochondrial metabolism in macrophages. Am J Physiol Cell Physiol 2021, 321(6):C1070-C1081.
  31. Abu Shelbayeh O, Arroum T, Morris S, Busch KB: PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel) 2023, 12(5).
  32. Maurice NM, Bedi B, Yuan Z, Lin KC, Goldberg JB, Hart CM, Bailey KL, Sadikot RT: The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection. Pathogens 2022, 11(2).
  33. Michi AN, Yipp BG, Dufour A, Lopes F, Proud D: PGC-1α mediates a metabolic host defense response in human airway epithelium during rhinovirus infections. Nat Commun 2021, 12(1):3669.
  34. Halling JF, Pilegaard H: PGC-1α-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab 2020, 45(9):927-936.
  35. Wenz T: Regulation of mitochondrial biogenesis and PGC-1α under cellular stress. Mitochondrion 2013, 13(2):134-142.
  36. Lonergan ZR, Skaar EP: Nutrient Zinc at the Host-Pathogen Interface. Trends Biochem Sci 2019, 44(12):1041-1056.
  37. Hara T, Yoshigai E, Ohashi T, Fukada T: Zinc in Cardiovascular Functions and Diseases: Epidemiology and Molecular Mechanisms for Therapeutic Development. Int J Mol Sci 2023, 24(8.
  38. Wessels I, Pupke JT, von Trotha KT, Gombert A, Himmelsbach A, Fischer HJ, Jacobs MJ, Rink L, Grommes J: Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity. Thorax 2020, 75(3):253-261.
  39. Johnson JK, Harris FL, Ping XD, Gauthier TW, Brown LAS: Role of zinc insufficiency in fetal alveolar macrophage dysfunction and RSV exacerbation associated with fetal ethanol exposure. Alcohol 2019, 80:5-16.
  40. Eijkelkamp BA, Morey JR, Neville SL, Tan A, Pederick VG, Cole N, Singh PP, Ong CY, Gonzalez de Vega R, Clases D et al.: Dietary zinc and the control of Streptococcus pneumoniae infection. PLoS Pathog 2019, 15(8):e1007957.
  41. Rink L, Kirchner H: Zinc-altered immune function and cytokine production. J Nutr 2000, 130(5S Suppl):1407S-1411S.
  42. Fraker PJ, King LE, Laakko T, Vollmer TL: The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000, 130(5S Suppl):1399S-1406S.
  43. Fraker PJ, King LE: Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004, 24:277-298.
  44. Maxfield L, Shukla S, Crane JS: Zinc Deficiency. In: StatPearls. Treasure Island (FL); 2024.
  45. Fischer Walker C, Black RE: Zinc and the risk for infectious disease. Annu Rev Nutr 2004, 24:255-275.
  46. Mocchegiani E, Giacconi R, Muzzioli M, Cipriano C: Zinc, infections and immunosenescence. Mech Ageing Dev 2000, 121(1-3):21-35.
  47. Barnett JB, Hamer DH, Meydani SN: Low zinc status: a new risk factor for pneumonia in the elderly? Nutr Rev 2010, 68(1):30-37.
  48. Lichten LA, Cousins RJ: Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009, 29:153-176.
  49. Bafaro E, Liu Y, Xu Y, Dempski RE: The emerging role of zinc transporters in cellular homeostasis and cancer. Signal Transduct Target Ther 2017, 2:17029.
  50. Hojyo S, Fukada T: Zinc transporters and signaling in physiology and pathogenesis. Arch Biochem Biophys 2016, 611:43-50.
  51. Alquethamy SF, Adams FG, Naidu V, Khorvash M, Pederick VG, Zang M, Paton JC, Paulsen IT, Hassan KA, Cain AK et al.: The Role of Zinc Efflux during Acinetobacter baumannii Infection. ACS Infect Dis 2020, 6(1):150-158.
  52. Costas J: The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2018, 177(2):274-283.
  53. Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA: Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet 2016, 48(7):709-717.
  54. Ye Z, Vasco DA, Carter TC, Brilliant MH, Schrodi SJ, Shukla SK: Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections. Front Genet 2014, 5:125.
  55. Bin BH, Seo J, Kim ST: Function, Structure, and Transport Aspects of ZIP and ZnT Zinc Transporters in Immune Cells. J Immunol Res 2018, 2018:9365747.
  56. Bedi B, Lin KC, Maurice NM, Yuan Z, Bijli K, Koval M, Hart CM, Goldberg JB, Stecenko A, Sadikot RT: UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis. Clin Sci (Lond) 2020, 134(14):1911-1934.
  57. Almontasheri A, Munshi A, Alsaedi A, Alsharief A, Albanna AS: Mycobacterium avium Complex Pulmonary Infection in a Patient With an SLC11A1 Mutation: A Rare Case Report and Review of Literature. Cureus 2023, 15(12):e50917.
  58. Weathered C, Pennington K, Escalante P, Pienaar E: The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection. J Theor Biol 2022, 534:110949.
  59. Rosenbloom R, Gavrish I, Tseng AE, Seidel K, Yabaji SM, Gertje HP, Huber BR, Kramnik I, Crossland NA: Progression and Dissemination of Pulmonary Mycobacterium Avium Infection in a Susceptible Immunocompetent Mouse Model. Int J Mol Sci 2022, 23(11).
  60. To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V: General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus. J Clin Med 2020, 9(8).
  61. Nishiuchi Y, Iwamoto T, Maruyama F: Infection Sources of a Common Non-tuberculous Mycobacterial Pathogen,. Front Med (Lausanne) 2017, 4:27.
  62. Dow A, Sule P, O’Donnell TJ, Burger A, Mattila JT, Antonio B, Vergara K, Marcantonio E, Adams LG, James N et al.: Zinc limitation triggers anticipatory adaptations in Mycobacterium tuberculosis. PLoS Pathog 2021, 17(5):e1009570.
  63. Healy C, Munoz-Wolf N, Strydom J, Faherty L, Williams NC, Kenny S, Donnelly SC, Cloonan SM: Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease. Respir Res 2021, 22(1):133.
Figure 1. Zinc deficiency during MAC infection reduces expression of key transcriptional regulators of mitochondrial biogenesis: U937 macrophages were cultured and introduced to zinc-deficient conditions for 48 hours prior to MAC infection (MOI 1) for 24 hours. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 1. Zinc deficiency during MAC infection reduces expression of key transcriptional regulators of mitochondrial biogenesis: U937 macrophages were cultured and introduced to zinc-deficient conditions for 48 hours prior to MAC infection (MOI 1) for 24 hours. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g001
Figure 2. Zinc deficiency during MAC infection damages mitochondria through reduction of ΔΨm and increased mitochondrial ROS production and reduces macrophage phagocytosis and bacterial killing: U937 macrophages were cultured and introduced to zinc-deficient conditions for 48 hours prior to MAC infection (MOI 1) for 24 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 2. Zinc deficiency during MAC infection damages mitochondria through reduction of ΔΨm and increased mitochondrial ROS production and reduces macrophage phagocytosis and bacterial killing: U937 macrophages were cultured and introduced to zinc-deficient conditions for 48 hours prior to MAC infection (MOI 1) for 24 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g002
Figure 3. ZP treatment rescues expression of mitochondrial PGC-1α and related cofactors during MAC infection: U937 macrophages were cultured and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 3. ZP treatment rescues expression of mitochondrial PGC-1α and related cofactors during MAC infection: U937 macrophages were cultured and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g003
Figure 4. Treatment with ZP aids in maintaining ΔΨm during MAC infection, reduces mitochondrial ROS production, and elevates macrophage antibacterial activity: U937 macrophages were cultured and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 24 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 4. Treatment with ZP aids in maintaining ΔΨm during MAC infection, reduces mitochondrial ROS production, and elevates macrophage antibacterial activity: U937 macrophages were cultured and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 24 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g004
Figure 5. ZIP8-KO reduces expression of key transcriptional regulators of mitochondrial biogenesis in BMDMs: BMDMs from both WT and Zip8-KO mice were cultured in normal media and infected with MAC (MOI 1) for 24 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 5. ZIP8-KO reduces expression of key transcriptional regulators of mitochondrial biogenesis in BMDMs: BMDMs from both WT and Zip8-KO mice were cultured in normal media and infected with MAC (MOI 1) for 24 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). Western blot results for PGC-1α (D) and TFAM (E), and representative blot images (C). ICC results for protein expression of PGC-1α (G), TFAM (H), and representative confocal images (F). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g005
Figure 6. ZIP8 KO BMDMs exhibit reduced ΔΨm, increased mitochondrial ROS production, and reduced macrophage antibacterial activity under zinc deficiency during MAC infection: BMDMs from both WT and Zip8-KO mice were cultured in normal media and infected with MAC (MOI 1) for 4 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 6. ZIP8 KO BMDMs exhibit reduced ΔΨm, increased mitochondrial ROS production, and reduced macrophage antibacterial activity under zinc deficiency during MAC infection: BMDMs from both WT and Zip8-KO mice were cultured in normal media and infected with MAC (MOI 1) for 4 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A, B). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (C). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (D). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (E). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g006
Figure 7. ZP treatment rescues ZIP8 KO BMDM expression of mitochondrial PGC-1α and related cofactors during MAC infection: BMDM from both WT and Zip8-KO mice were cultured in normal media and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). ICC results for protein expression of PGC-1α (D), TFAM (E), and representative confocal images (C). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 7. ZP treatment rescues ZIP8 KO BMDM expression of mitochondrial PGC-1α and related cofactors during MAC infection: BMDM from both WT and Zip8-KO mice were cultured in normal media and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. PCR results for mRNA expression of ppargc1a (A) and tfam (B). ICC results for protein expression of PGC-1α (D), TFAM (E), and representative confocal images (C). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g007
Figure 8. ZP attenuates ZIP8 KO BMDM mitochondrial damage and deficits in macrophage activity during MAC infection: BMDM from both WT and Zip8-KO mice were cultured in normal media and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (B). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (C). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (D). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Figure 8. ZP attenuates ZIP8 KO BMDM mitochondrial damage and deficits in macrophage activity during MAC infection: BMDM from both WT and Zip8-KO mice were cultured in normal media and treated with ZP [50 µM] for 48 hours prior to infection with MAC (MOI 1) for 4 hours prior to all analyses. Cells were stained with MitoTracker Green, TMRM, and Hoechst to evaluate mitochondrial membrane integrity, and presented as relative fluorescence of TMRM/MTG per Hoechst-positive cell (A). Mitochondria superoxide production was evaluated through staining with MitoSOX and measuring fluorescence expression within cells (B). Phagocytic uptake was determined through incubating cells with fluorescent BioParticles for 2 hours and evaluating fluorescence expression to determine cellular uptake (C). Bacterial killing was evaluated through CFU counting on 7H9 agar plates (D). Results are averages of experiments performed in triplicate with SEM. *p<0.05, **p<0.01, ***p<0.005, ****p<0.001.
Preprints 168439 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated